title: The effects of vasopressin and oxytocin on methamphetamine-induced place preference behaviour in rats.
abstract: Methamphetamine is a highly addictive stimulant drug whose illicit use and resultant addiction has become an alarming global phenomenon. The mesolimbic dopaminergic pathway has been shown to be fundamental to the establishment of addictive behaviour. This pathway, as part of the reward system of the brain, has also been shown to be important in classical conditioning, which is a learnt response. Within the modulation of learning and memory, the neurohypophyseal hormones vasopressin and oxytocin have been reported to play a vital role, with vasopressin exerting a long- term facilitatory effect and oxytocin exerting an inhibitory effect. Therefore we adopted a conditioned place preference model to investigate whether vasopressin V1b receptor antagonist SSR 149415 or oxytocin treatment would cause a decrease in the seeking behaviour in a reinstatement paradigm. Behavioural findings indicated that methamphetamine induced a change in the place preference in the majority of our animals. This change in place preference was not seen when vasopressin was administered during the extinction phase. On the other hand the methamphetamine-induced change in place preference was enhanced during the reinstatement phase in the animals that were treated with oxytocin. Striatal dopamine levels were determined, as methamphetamine is known to increase dopamine transmission in this area. Significant changes in dopamine levels were observed in some of our animals. Rats that received both methamphetamine and oxytocin had significantly higher striatal dopamine than those that received oxytocin alone. Western blot analysis for hippocampal cyclic AMP response element binding protein (CREB) was also conducted as a possible indicator of glutamatergic NMDA receptor activity, a pathway that is important for learning and memory. The Western blot analysis showed no changes in hippocampal pCREB expression. Overall our data led us to conclude that methamphetamine treatment can change place preference behaviour in rats and that this change may be partially restored by vasopressin antagonism, but exaggerated by oxytocin.
authors.affiliation: Discipline of Human Physiology, College of Health Science, University of KwaZulu-Natal, Durban, South Africa. subiah@ukzn.ac.za
authors.forename: Cassandra O
authors.initials: CO
authors.lastname: Subiah
authors.forename: Musa V
authors.initials: MV
authors.lastname: Mabandla
authors.forename: Alisa
authors.initials: A
authors.lastname: Phulukdaree
authors.forename: Anil A
authors.initials: AA
authors.lastname: Chuturgoon
authors.forename: Willie M U
authors.initials: WM
authors.lastname: Daniels
mesh_terms: D019969:Amphetamine-Related Disorders / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D000818:Animals; D000697:Central Nervous System Stimulants / Q000037:antagonists & inhibitors / Q000633:toxicity; D004195:Disease Models, Animal; D008297:Male; D008694:Methamphetamine / Q000037:antagonists & inhibitors* / Q000633:toxicity; D010121:Oxytocin / Q000494:pharmacology* / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D014667:Vasopressins / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000502:physiology
chemical_list: D000697:Central Nervous System Stimulants; D014667:Vasopressins; D008694:Methamphetamine; D010121:Oxytocin